[Source]
During COVID-19, the U.S. Food and Drug Administration (FDA) will continue to utilize and implement additional alternative inspection tools and approaches while postponing domestic and foreign routine surveillance inspections. Read more...
Neovii has signed a research and license agreement with Tel Aviv University's (TAU) RAMOT, its technology transfer company, to work in collaboration with a team led by Professor Jonathan Gershoni of the School of Molecular Cell Biology and Biotechnology to develop a novel COVID-19 vaccine. Read more...